Management of the process of supply of convalescent plasma
Bulgarskii Meditsinski Zhurnal / Bulgarian Medical Journal
; 16(1):42-49, 2022.
Article
in Bulgarian
| GIM | ID: covidwho-1888259
ABSTRACT
For the treatment of coronavirus disease 2019 (COVID-19), health systems have developed disease management strategies. The use of convalescent plasma in patients with severe acute respiratory syndrome (Sars-Cov-2) is recommended. The use of plasma from a donor who has survived COVID-19 is potentially expected to have a good effect.
blood plasma; coronavirus disease 2019; human diseases; viral diseases; patients; blood transfusion; public health; haematology; health services; legislation; nurses; therapy; Severe acute respiratory syndrome coronavirus 2; man; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; plasma (blood); SARS-CoV-2; viral infections; hematology; therapeutics
Search on Google
Collection:
Databases of international organizations
Database:
GIM
Language:
Bulgarian
Journal:
Bulgarian Medical Journal
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS